Opeyemi T. Aroyewun, MD
Pulmonary Disease Physician · Austin, TX
Opeyemi T. Aroyewun, MD is a pulmonary disease physician with a practice address in Austin, Texas, and NPI 1669096525, issued on Jun 5, 2020. Check the license (Texas U8025, as entered in NPPES) on the Texas Medical Board; the Medicare figures below come from public CMS files.
- Name
- Opeyemi T. Aroyewun
- Credential
- MD
- Primary taxonomy
- Pulmonary Disease Physician 207RP1001X
- License number
- U8025 TX
Self-reported in NPPES; status is on the state search - Practice location
- 1301 W 38TH St Ste 400, Austin, TX 78705
- Phone
- (512) 324-3340
- Enumerated
- Jun 5, 2020
- Record last updated
- May 15, 2026
- Medicare enrollment
- Enrolled (PECOS I20241127001033); accepts Medicare assignment
- Entity
- Type 1 · individual
8 nearest pulmonary disease physician records → All 967 in Texas → Look up another NPI →
Also registered at 1301 W 38TH St Ste 400
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Saad Ahmad, DOInternal Medicine Physician1861021545
- Mohammad Alsumrain, M.DPulmonary Disease Physician1639327885
- Holly Gureski, APRNAcute Care Nurse Practitioner1053985671
- Stanley HoyPulmonary Disease Physician1043660228
- Caleb Taylor, MDPulmonary Disease Physician1508248451
- Pedro Teixeira, MDVascular Surgery Physician1851692784
Verify Opeyemi T. Aroyewun in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersTexas Medical Board
Search for license U8025Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
95% fewer Medicare Part D claims than the average pulmonary disease physician in 2024
73 Medicare Part D claims for 17 beneficiaries, against an average of 1,425 among the 11,596 providers of this specialty who prescribed in Part D. Brand-name drugs were 64% of claims.
Most prescribed
- Breztri Aerosphere13 claims
- Montelukast Sodium11 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $40.25
1 payment: food and beverage; the largest payer was Genzyme Corporation. The 8,806 providers of this specialty with any payment received $5,159.88 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through one group practice
- Seton Family OF DoctorsAustin, TX
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Opeyemi T. Aroyewun among 967 pulmonary disease physician records in Texas
Opeyemi T. Aroyewun, MD is one of 967 pulmonary disease physician records with a practice address in Texas. 88% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2020, is newer than 97% of them.
- NPI issued2020 · 97% of these records are older, 1% newer
- In a Medicare fileYes · 88% of these records are
- In the CMS Doctors and Clinicians fileYes · 80% of these records are
- Graduated2018 · median 2001 among the 773 with a school on file
- Record last updated2026 · 48% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RP1001X and a Texas practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Pulmonary Disease Physician providers in Texas
There are 967 pulmonary disease physician records in Texas.
All 967 in Texas → Every provider in Austin → Pulmonary Disease Physician nationwide →
The 8 pulmonary disease physician records with the nearest ZIP codes
- Mohammad Alsumrain, M.DAustin, TX 787051639327885
- John Dallas, MDAustin, TX 787051972687127
- William Deaton, M.D.Austin, TX 787051962435461
- Anna Dvorak, MDAustin, TX 787051477712891
- Shailaja Hayden, M.D.Austin, TX 787051427226224
- Stanley HoyAustin, TX 787051043660228
- Raj Keriwala, MDAustin, TX 787051073775524
- Robert Morrison, M.D.Austin, TX 787051750307757
Common questions
What is Opeyemi T. Aroyewun, MD's NPI number?
Opeyemi T. Aroyewun, MD's National Provider Identifier (NPI) is 1669096525, issued on Jun 5, 2020. An NPI identifies a provider in billing; it is not a license.
Where is Opeyemi T. Aroyewun, MD located?
The NPPES record lists a practice address at 1301 W 38TH St Ste 400, Austin, TX, 78705. Phone: (512) 324-3340. Providers update this record themselves, so call before visiting.
How can I verify Opeyemi T. Aroyewun, MD's license?
NPPES lists Texas license number U8025, as entered by the provider. Search the Texas Medical Board at https://profile.tmb.state.tx.us/Search.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Opeyemi T. Aroyewun, MD prescribe under Medicare Part D?
In 2024, Opeyemi T. Aroyewun, MD had 73 Medicare Part D claims for 17 beneficiaries; the average among pulmonary disease physician prescribers was 1,425. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.